http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083907-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef3e73bf82e05dd388bd59b6da624736
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1998-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3910494b7af425d51f142f9cc6e5d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88ac1962b8c6af5c1e22b009d267bc9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3513fa1929000e415a40fda02238d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59392e71812d3d80b637eaf4f665d3ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d17d812aad17c8f3131ef4a991316468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f290e3032553084081a6e88648203d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9abbdf084e82ab8a94c9ce9f2236307b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53afad9068013472009d9270cb503316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563bbd4dc3b7c8ce155bb63dbb2caeb7
publicationDate 2000-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6083907-A
titleOfInvention Treatment of peptic ulcers using midkine (MK) proteins
abstract An anti-ulcer composition is provided, which comprises as an active ingredient at least one of MK protein, its derivative having biological activity of MK protein, and their fragment having biological activity of MK protein, and a pharmaceutically acceptable carrier. The composition exhibits an effect for treating ulcer by promoting autotherapy without recurrence of ulcer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004052928-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1621620-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008107659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003072739-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9163081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010311187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006216709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086906-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003181657-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637541-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7193047-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587654-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7390491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005260647-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005079151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004052928-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8716230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8106009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1621620-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587654-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7288384-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637541-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7300758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7309695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006051779-A1
priorityDate 1995-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5210026-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128328645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378

Total number of triples: 80.